Phathom Pharmaceuticals, Inc. (PHAT)
13.19
+0.58
(+4.60%)
USD |
NASDAQ |
Apr 17, 16:00
13.18
-0.01
(-0.08%)
Pre-Market: 20:00
Phathom Pharmaceuticals SG&A Expense (Quarterly) : 48.37M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Replimune Group, Inc. | 18.73M |
| ANI Pharmaceuticals, Inc. | 82.79M |
| MannKind Corp. | 58.41M |
| Ocugen, Inc. | 6.132M |
| Ligand Pharmaceuticals, Inc. | 25.03M |